Life Technologies Prices Offering of Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that it has priced an offering of senior notes.

The offering of $400 million aggregate principal amount of 3.5 percent senior notes due 2016 have an issue price of 99.84 percent of their face value. $400 million aggregate principal amount of 5 percent senior notes due 2021 have an issue price of 99.556 percent of their face value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.